Search
Avita Medical's ReCell regenerative medicine technology.

Avita taps investors for $17m

The company commercialising an innovative spray-on burns treatment co-developed by medical entrepreneur Fiona Wood has launched a $17 million capital raising.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 28/09/18

1 year TSR5 year TSR
107thAvita Medical78%-0%
223rdI Synergy Group31%0%
325thKatana Capital12%4%
349thMustera Property Group6%0%
714thAdmedus-48%-31%
739 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

29/12/17
$75k Bought
29/12/17
$10k Bought
28/12/17
$5k Bought
Total value as at the date of the transaction
Source: Morningstar

Revenue

84th↓Admedus$11.7m
85th↑Mustera Property Group$11.4m
86th↑Avita Medical$11.3m
87th↑I Synergy Group$10.8m
88th↑Katana Capital$10.3m
239 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer